Expression and significance of glypican-3 in colorectal cancer

National Medical Journal of China

Volumn 88, Issue 22, 2008, Pages 1540-1542

  Yuan, Dong Hong ^a   Xie, Hua Hong ^b   Wang, Yan ^b   Meng, Cun Ying ^b   Yang, Li Ping ^b   Feng, Yi Chao ^b   Song, Jiu Gang ^b   Zou, Xue ^b   Wu, Kai Chun ^b   Liu, Jie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Glypican 3; Immunohistochemistry; Intestinal neoplasms

Indexed keywords

GLYPICAN 3;

AGE; ARTICLE; CANCER INVASION; CELL MEMBRANE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

COLORECTAL NEOPLASMS; FEMALE; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 50249154009     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Pilia G, Hughes-Benzie RM, MacKenzie A, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet, 1996,12 f31:241-247.
2. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican3 oncofetal protein is a promising diagnostic marker for hepetocellular carcinoma. Mod Pathol, 2005, 18: 1591-1598.
3. Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res,1997,57:5179-5184.
4. Chinese source.
5. Chinese source.
6. Song HH, Shi W, Xiang YY, et al. The loss of Glypican-3 induces alterations in Wnt signaling. J Biol Chem, 2005, 280: 2116-2125.
7. Kwack MH, Choi BY, Sung YK. Cellular changes resulting from forced expression of glypican23 in hepatocellular carcinoma cells. Histol Histopathol Mol Cells, 2006, 21:224-228.
8. Capurro MI, Xiang YY, Lobe C, et al. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res, 2005, 65:6245-6254.
9. Lin H, Huber R, Schlessinger D, et al. Frequent silencing of the GLYPICAN-3 gene in ovarian cancer cell lines. Cancer Res, 1999, 59: 807-810.
10. Gonzalez AD, Kaya M, Shi W, et al. oci glypican-3, a glypican encoded by a gene that is mutated in the Simpson- Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol, 1998, 141:1407-1414.
11. Peters MG, Farias E, Colombo L, et al. Inhibition of invasionand metastasis by Glypican-3 in a syngeneic breastcancer model. Breast Cancer Res Treat,2003, 80:221-232.
12. Farooq M, Hwang SY, Park MK, et al. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest. Mol Cells, 2003,15:356-360.
13. Capurro M, Wanless IR, Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellularcarcinoma. Gastroenterology, 2003, 125: 89-97.